Twist生物科学首席执行官、SVP和内幕人士出售了Q2损失后的股票,超过了收入估计数。 Twist Bioscience CEO, SVP, and insider sold shares post-Q2 loss, surpassing revenue estimates.
Twist生物科学公司(NASDAQ:TWST)首席执行官Emily Leproust、SVP Paula Green和内幕人Dennis Cho出售公司股份,Leproust拥有499 593个股份,Green拥有88 837个交易后股份。 Twist Bioscience Co.'s (NASDAQ: TWST) CEO Emily Leproust, SVP Paula Green, and insider Dennis Cho sold shares of the company, with Leproust owning 499,593 shares and Green owning 88,837 shares post-transactions. Twist Bioscience的股票市值为25.8亿美元，第二季度每股亏损1.47美元，超过收入预期的8150万美元。 Twist Bioscience's stock has a market cap of $2.58 billion and reported a Q2 loss of $1.47 per share, exceeding revenue estimates at $81.50 million. 该公司侧重于各种应用的合成DNA产品,协商一致的目标价格为48.22美元。 The company focuses on synthetic DNA-based products for various applications and has a consensus target price of $48.22.